Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by d3rider2k5on Jan 27, 2018 4:48pm
209 Views
Post# 27447869

RE:RE:RE:RE:RE:RE:RE:RE:RE:Aurora Sky Facility - I TOLD YOU SO!

RE:RE:RE:RE:RE:RE:RE:RE:RE:Aurora Sky Facility - I TOLD YOU SO!Trying to compare companies based on market cap for #1 or whatever metric is used to compare the #1 vs #2 etc is trivial in my mind. Even looking at the number of patients a company has listed is also trivial at this point. 

We are about to allow recreational MJ in Canada....the number of patients you have when this happens is going to be peanuts. The only thing about having patients is going to hopefully be brand loyalty at most. And that they are a guarunteed source of profits...but again this will change drastically. Look at Big Pharma, they are losing many profits right now to generic drugs that are on the market. They are forced to have "compensation" cards to patients that say they will agree to allow the patient to get the brand name drug at the price of the generic and the company picks up the tab. This is only to start creating more focus back on the brands.

So again, things will certianly change in my view and the number of patients you have won't be a major difference at all. 

Brand awareness, and how you diversify yourself will be the difference makers. Look at Samsung vs Apple or Google vs Yahoo. They all have arguably similar targets but they have diversified and differentiated themselves to become leaders in their areas. So using that as an example, I think it is safe to say the same rules will be applied here as well or at the very least to some degree. 
Bullboard Posts